Response of 3-months-old infants to 3 doses of trivalent oral poliomyelitis vaccine.
作者信息
PERKINS F T, YETTS R, GAISFORD W
出版信息
Br Med J. 1963 Jun 15;1(5345):1573-4. doi: 10.1136/bmj.1.5345.1573.
Abstract
摘要
相似文献
1
Response of 3-months-old infants to 3 doses of trivalent oral poliomyelitis vaccine.
Br Med J. 1963 Jun 15;1(5345):1573-4. doi: 10.1136/bmj.1.5345.1573.
2
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26.
3
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Lancet. 2016 Jul 9;388(10040):158-69. doi: 10.1016/S0140-6736(16)00703-0. Epub 2016 May 19.
4
Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules.
Pediatrics. 1970 Mar;45(3):444-8.
5
6
Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
Vaccine. 2016 Mar 14;34(12):1436-43. doi: 10.1016/j.vaccine.2016.02.010. Epub 2016 Feb 9.
7
Early immunization of neonates with trivalent oral poliovirus vaccine.
Bull World Health Organ. 1992;70(1):85-91.
8
[Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
Vopr Virusol. 1979 May-Jun(3):252-9.
9
[POLIOMYELITIS VACCINATION OF NEWBORN AND OTHER INFANTS].
Ann Paediatr. 1963;201:64-9.
10
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1.
引用本文的文献
1
A Single-Dose Intranasal Combination Panebolavirus Vaccine.
J Infect Dis. 2023 Nov 13;228(Suppl 7):S648-S659. doi: 10.1093/infdis/jiad266.
2
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01845-18. Print 2019 Feb 15.
3
CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
Can Med Assoc J. 1964 Nov 21;91(21):1118-22.
4
Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants.
Br Med J. 1969 Mar 15;1(5645):663-6. doi: 10.1136/bmj.1.5645.663.
5
A survey of enteroviruses and adenoviruses in the faeces of normal children aged 0-4 years. A report of the Public Health Laboratory Service and the Society of Medical Officers of Health.
J Hyg (Lond). 1965 Dec;63(4):441-55. doi: 10.1017/s0022172400045344.
6
Immunization in India with trivalent and monovalent oral poliovirus vaccines of enhanced potency.
Bull World Health Organ. 1976;54(1):115-7.
本文引用的文献
1
British standard poliomyelitis antisera types 1, 2, and 3.
Br Med J. 1959 Jun 20;1(5137):1549-53. doi: 10.1136/bmj.1.5137.1549.
2
Clinical trials in infants of orally administered attenuated poliomyelitis viruses.
Pediatrics. 1959 Jun;23(6):1041-62.
Zotero 插件